Get the Stockscreener App
58.73
0.12%
0.095
Centene Corp stock is traded at $58.73, with a volume of 1.34M.
It is up +0.12% in the last 24 hours and down -6.25% over the past month.
Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract.
See More
Previous Close:
$58.63
Open:
$59.06
24h Volume:
1.34M
Relative Volume:
0.25
Market Cap:
$29.08B
Revenue:
$161.73B
Net Income/Loss:
$3.07B
P/E Ratio:
10.20
EPS:
5.76
Net Cash Flow:
$245.00M
1W Performance:
-8.32%
1M Performance:
-6.25%
6M Performance:
-21.50%
1Y Performance:
-21.65%
1-Day Range:
$58.30
$59.27
1-Week Range:
$57.90
$66.81
52-Week Range:
$55.03
$81.42
Centene Corp Stock (CNC) Company Profile
Name
Centene Corp
Sector
Industry
Phone
(314) 725-4477
Address
7700 FORSYTH BLVD., ST LOUIS
Compare CNC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
58.70 | 29.08B | 161.73B | 3.07B | 245.00M | 5.76 |
|
UNH
Unitedhealth Group Inc
|
530.28 | 489.45B | 400.28B | 14.41B | 20.71B | 15.50 |
|
ELV
Elevance Health Inc
|
392.90 | 90.56B | 176.81B | 5.98B | 4.55B | 25.60 |
|
CI
Cigna Group
|
287.58 | 78.64B | 244.32B | 3.43B | 5.18B | 12.24 |
|
CVS
Cvs Health Corp
|
54.29 | 62.83B | 368.91B | 5.02B | 1.69B | 3.94 |
|
HUM
Humana Inc
|
278.79 | 33.66B | 115.01B | 1.36B | -4.34B | 11.29 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Dec-13-24 | Upgrade | UBS | Neutral → Buy |
| Dec-10-24 | Downgrade | Jefferies | Hold → Underperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Mar-21-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-05-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-20-23 | Initiated | UBS | Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-23-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-30-22 | Initiated | Argus | Buy |
| Aug-26-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-28-22 | Resumed | Barclays | Overweight |
| Jul-14-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-21-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Resumed | Bernstein | Outperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-07-22 | Resumed | Barclays | Overweight |
| Jan-06-22 | Resumed | JP Morgan | Overweight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Reiterated | BMO Capital Markets | Outperform |
| Dec-13-21 | Reiterated | BofA Securities | Buy |
| Dec-13-21 | Reiterated | Credit Suisse | Neutral |
| Dec-13-21 | Reiterated | Mizuho | Neutral |
| Dec-13-21 | Reiterated | Oppenheimer | Outperform |
| Dec-13-21 | Reiterated | Stephens | Overweight |
| Dec-13-21 | Reiterated | Truist | Buy |
| Dec-13-21 | Reiterated | Wells Fargo | Overweight |
| Dec-13-21 | Reiterated | Wolfe Research | Outperform |
| Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-19-21 | Initiated | Wells Fargo | Overweight |
| May-11-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-10-21 | Initiated | Mizuho | Neutral |
| Jan-21-21 | Resumed | Goldman | Neutral |
| Jan-15-21 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Feb-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-03-20 | Resumed | Evercore ISI | Outperform |
| Jan-28-20 | Reiterated | Bernstein | Outperform |
| Jan-06-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| May-10-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Oct-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Jul-18-18 | Resumed | Citigroup | Neutral |
| Dec-18-17 | Reiterated | Jefferies | Buy |
| Sep-13-17 | Reiterated | Leerink Partners | Mkt Perform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-22-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
| Mar-23-17 | Downgrade | Citigroup | Buy → Neutral |
| Feb-08-17 | Reiterated | Barclays | Overweight |
| Feb-07-17 | Resumed | Cantor Fitzgerald | Overweight |
| Jan-04-17 | Initiated | Piper Jaffray | Overweight |
View All
Centene Corp Stock (CNC) Latest News
Centene cut to Hold at Argus amid Medicare and Medicaid uncertainty - Yahoo Finance
Chicago Partners Investment Group LLC Makes New Investment in Centene Co. (NYSE:CNC) - MarketBeat
Centene (NYSE:CNC) Shares Gap DownWhat's Next? - MarketBeat
Do Wall Street Analysts Like Centene Stock? - Nasdaq
Centene Co. (NYSE:CNC) Shares Sold by Retirement Systems of Alabama - MarketBeat
Earnings call transcript: Centene Q4 2024 beats EPS forecast, stock dips - MSN
Brokerages Set Centene Co. (NYSE:CNC) PT at $80.92 - MarketBeat
Mediolanum International Funds Ltd Grows Position in Centene Co. (NYSE:CNC) - MarketBeat
Centene Corp (CNC) Q4 2024 Earnings Call Highlights: Strong EPS and Revenue Guidance Boost - GuruFocus.com
Discover Why Centene Corporation Plummeted Despite Promising Earnings! - Jomfruland.net
Centene Corporation (NYSE:CNC) Q4 2024 Earnings Call Transcript - Insider Monkey
Why Centene Corporation (CNC) Went Down on Tuesday - Insider Monkey
Centene Earnings: Strong End to 2024, but 2025 Outlook Only Kept Intact; Shares Still Undervalued - Morningstar
Centene Corporation Reports Strong 2024 Financial Performance - TipRanks
Centene: Q4 Earnings Snapshot - CT Insider
Here's How Much $100 Invested In Centene 20 Years Ago Would Be Worth Today - Benzinga
Centene Q4 Earnings Beat Estimates on Membership Growth, 2025 View Up - MSN
Centene Q4 Earnings Beat Estimates On Membership Growth, 2025 View Up - Barchart
Centene's shares slip on higher Medicaid costs - Reuters
Insurance Firm Centene Sees Q4 Revenue Boost, Sticks To Annual Forecast - Benzinga
Robert W. Baird Increases Centene (NYSE:CNC) Price Target to $71.00 - MarketBeat
Centene posts $3.3B profit for 2024, boosted by Medicare drug plan and Obamacare - The Business Journals
Centene (NYSE:CNC) Updates FY 2025 Earnings Guidance - MarketBeat
Earnings call transcript: Centene Q4 2024 beats EPS forecast, stock dips By Investing.com - Investing.com South Africa
Elevance Health, Centene donated to Trump inaugural fund, key lawmakers - Fierce healthcare
(CNC)Analyzing Centene's Short Interest - Benzinga
Centene (CNC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Centene's lower medical costs drive Q4 profit - Modern Healthcare
Centene (NYSE:CNC) Releases Quarterly Earnings Results, Beats Estimates By $0.36 EPS - MarketBeat
Centene (NYSE:CNC) Beats Expectations in Strong Q4 By Stock Story - Investing.com Canada
Centene (CNC) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
Centene Corp (CNC) Q4 Earnings: EPS of $0.56 Beats Estimate, Rev - GuruFocus.com
Centene earnings beat by $0.29, revenue topped estimates - Investing.com
Centene (CNC) Beats Estimates on Better Controlled Medical Expenses - Bloomberg
Centene: Q4 Earnings Snapshot -February 04, 2025 at 06:20 am EST - Marketscreener.com
Centene reports Q4 earnings beat, raises 2025 revenue outlook - Investing.com
Centene reports Q4 earnings beat, raises 2025 revenue outlook By Investing.com - Investing.com South Africa
Centene (NYSE:CNC) Beats Expectations in Strong Q4 - Yahoo Finance
CENTENE CORPORATION REPORTS 2024 RESULTS - Yahoo Finance
Centene Co. (NYSE:CNC) Shares Bought by Pacer Advisors Inc. - MarketBeat
Health Care Stocks Rise After Trump Vows To 'Love and Cherish' Medicare, Medicaid - Investopedia
Centene Co. (NYSE:CNC) Shares Sold by Scharf Investments LLC - MarketBeat
Unlocking Q4 Potential of Centene (CNC): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
OLD National Bancorp IN Sells 4,042 Shares of Centene Co. (NYSE:CNC) - MarketBeat
Osborne Partners Capital Management LLC Purchases 10,515 Shares of Centene Co. (NYSE:CNC) - MarketBeat
Centene Co. (NYSE:CNC) Shares Sold by Swedbank AB - MarketBeat
Centene Corporation (CNC): Among the Large-Cap Stocks Insiders Are Buying Recently - Insider Monkey
Centene Co. (NYSE:CNC) Shares Sold by Fifth Third Bancorp - MarketBeat
Centene (CNC) Expected to Announce Earnings on Tuesday - MarketBeat
Centene Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Centene Corp Stock (CNC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):